PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Clinical trials for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to restore blood counts in bone marrow failure
Disease control Recruiting nowThis study tests a mix of drugs that calm the immune system and boost white blood cells in people with aplastic anemia or certain types of MDS. The goal is to improve low blood counts by targeting immune cells that may be attacking the bone marrow. About 140 adults will take part…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Virus-Based therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Immune boosting cells show promise in fighting blood cancers after transplant
Disease control Recruiting nowThis study tests whether giving patients personalized natural killer (NK) cells after chemotherapy and a cord blood transplant can help kill remaining cancer cells and reduce complications. It includes 100 adults with various blood cancers like leukemia, lymphoma, or multiple mye…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) in people with acute myeloid leukemia, high-risk myelodysplastic syndrome, or a fast-growing form of chronic myeloid leukemia. The goal is to see how well these drugs ki…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:20 UTC